Cantor Fitzgerald Weighs in on YMAB FY2026 Earnings
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for Y-mAbs Therapeutics in a research note issued on Monday, June 9th. Cantor Fitzgerald analyst L. Watsek forecasts that the company will post earnings of ($1.04) per share for the year. The consensus estimate for Y-mAbs […]
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for Y-mAbs Therapeutics in a research note issued on Monday, June 9th. Cantor Fitzgerald analyst L. Watsek forecasts that the company will post earnings of ($1.04) per share for the year. The consensus estimate for Y-mAbs […]
